David Rosa - Intuitive Surgical Chief Commercial Officer and Executive VP
| ISRG Stock | USD 488.15 11.83 2.48% |
EVP
Mr. David J. Rosa is Executive Vice President, Chief Commercial Officer of the Company. Mr. Rosa joined Intuitive Surgical in March 1996 and has held leadership positions in engineering, clinical development, marketing and product development. In April 2011, Mr. Rosa was promoted to the position of Senior Vice President, Emerging Procedures Technology and transitioned to the position of Senior Vice President, Scientific Affairs. In August 2014, Mr. Rosa was promoted to the position of Executive Vice President and Chief Scientific Officer. In June 2015, Mr. Rosa was appointed as Executive Vice President and Chief Commercial Officer. In January 2019, Mr. Rosa took on additional responsibility as Executive Vice President and Chief Business Officer. Prior to joining Intuitive Surgical, Mr. Rosa contributed to the development of transesophageal transducers for Acuson Corporationrationration. Mr. Rosa also currently serves on the boards of directors of Kardium Inc. and Arterys Inc since 2015.
| Age | 58 |
| Tenure | 11 years |
| Address | 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304 |
| Phone | 408 523 2100 |
| Web | https://www.intuitive.com |
David Rosa Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Rosa against Intuitive Surgical stock is an integral part of due diligence when investing in Intuitive Surgical. David Rosa insider activity provides valuable insight into whether Intuitive Surgical is net buyers or sellers over its current business cycle. Note, Intuitive Surgical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Intuitive Surgical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Rosa over a year ago Acquisition by David Rosa of 75930 shares of Biotricity subject to Rule 16b-3 |
Intuitive Surgical Management Efficiency
The company has return on total asset (ROA) of 0.0939 % which means that it generated a profit of $0.0939 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1669 %, meaning that it created $0.1669 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Intuitive Surgical's Return On Assets are most likely to increase slightly in the upcoming years. At this time, Intuitive Surgical's Other Current Assets are most likely to increase significantly in the upcoming years. The Intuitive Surgical's current Total Current Assets is estimated to increase to about 10.3 B, while Other Assets are projected to decrease to roughly 1.1 B.Management Performance
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0939 |
Intuitive Surgical Leadership Team
Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Rosa, Chief Commercial Officer and Executive VP | ||
| Mark Brosius, Senior Officer | ||
| CFA CFA, VP Relations | ||
| Milind Wagle, Chief Officer | ||
| Gary Loeb, G Officer | ||
| Robert DeSantis, Executive Officer | ||
| Philip Kim, Head Relations | ||
| Patricia Wadors, Chief Officer | ||
| Ian Purdy, Senior Assurance | ||
| Julian Nikolchev, Sr Strategy | ||
| Gillian EdD, Senior ServicesWorldwide | ||
| Dirk Barten, Senior Marketing | ||
| Jamie Samath, Principal Accounting Officer, VP and Corporate Controller | ||
| Gary JD, Executive Officer | ||
| Daniel CFA, VP Relations | ||
| Brian King, Treasurer VP | ||
| Gary Guthart, CEO and President and Director | ||
| Marc Bland, GM VP | ||
| MD FACS, Executive Officer | ||
| Glenn Vavoso, Senior Pacific | ||
| Brian Miller, Executive Officer | ||
| Henry Charlton, Executive Officer | ||
| Fredrik Widman, Principal VP | ||
| Marshall Mohr, Executive Services | ||
| Christopher Carlson, Corporate Research |
Intuitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0939 | ||||
| Profit Margin | 0.28 % | ||||
| Operating Margin | 0.30 % | ||||
| Current Valuation | 163.99 B | ||||
| Shares Outstanding | 355.13 M | ||||
| Shares Owned By Insiders | 0.53 % | ||||
| Shares Owned By Institutions | 88.80 % | ||||
| Number Of Shares Shorted | 7.14 M | ||||
| Price To Earning | 69.96 X |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Intuitive have expansion opportunities? Factors like these will boost the valuation of Intuitive Surgical. Market participants price Intuitive higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Intuitive Surgical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 0.166 | Earnings Share 7.86 | Revenue Per Share | Quarterly Revenue Growth 0.188 | Return On Assets |
Understanding Intuitive Surgical requires distinguishing between market price and book value, where the latter reflects Intuitive's accounting equity. The concept of intrinsic value - what Intuitive Surgical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Intuitive Surgical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Intuitive Surgical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.